Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2018 033 882.9 |
96 | EP file number | EAKZ | 18 81 3582.6 |
86 | WO file number | WAKZ | PCT/CN2018/089996 |
97 | EP publication number | EPN | 3620455 |
87 | WO publication number | WPN | 2018223970 |
54 | Designation/title | TI | NEUES VERFAHREN ZUR HERSTELLUNG VON ESCITALOPRAM-PAMOAT |
51 | IPC main class | ICM (ICMV) | C07D 307/87 (2006.01) |
22 | DE application date | DAT | Jun 5, 2018 |
96 | EP application date | EAT | Jun 5, 2018 |
86 | WO application date | WAT | Jun 5, 2018 |
43 | Date of first publication | OT | Dec 13, 2018 |
| Date of publication of grant | PET | Apr 13, 2022 |
71/73 | Applicant/owner | INH | Shanghai Aobo bio-pharmaceutical Co., Ltd., Shanghai, CN; Zhejiang Huahai Pharmaceutical Co., Ltd, Taizhou, Zhejiang, CN |
72 | Inventor | IN | XU, Wei, Shanghai 201203, CN; CHEN, Xi, Shanghai 201203, CN; GU, Hong, Shanghai 201203, CN |
74 | Representative | VTR | Dantz IP & Law, 10719 Berlin, DE |
| Address for service | | Dantz IP & Law, 10719 Berlin, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| CN 201710411925 Jun 5, 2017
|
| Due date | FT FG | Jun 30, 2025 Annual fee for the 8th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003620455A1 Searchable text:
EP000003620455A1 Original document:
EP000003620455B1 Searchable text:
EP000003620455B1 Original document:
WO002018223970 Searchable text:
WO002018223970 |
43 | Date of first publication | EVT | Dec 13, 2018 |
| Date of the first transfer into DPMAregister | EREGT | Mar 11, 2020 |
| Date of the (most recent) update in DPMAregister | REGT | Oct 10, 2024 (Show all update days)(Hide all update days)- Oct 10, 2024
- St.36: changed (technical change)
- Jun 21, 2024; May 16, 2024; Jul 27, 2023; Jul 5, 2023; Jun 22, 2023; Mar 30, 2023; Mar 2, 2023; Jul 9, 2022; May 20, 2022; Apr 28, 2022; Mar 24, 2022
- Historical data not available for this/these date(s)
- Mar 11, 2020
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 8)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jul 4, 2023 |
| Issue number | HN | 32 |
| Year | PJ | 2023 |
| Publication date | VT | Aug 10, 2023 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Shanghai Aobo bio-pharmaceutical Co., Ltd., Shanghai, CN; Zhejiang Huahai Pharmaceutical Co., Ltd, Taizhou, Zhejiang, CN |
71/73 | Previous applicant/owner | INHF | Shanghai Aobo Pharmtech, Inc., Ltd., Shanghai, CN, Zhejiang Huahai Pharmaceutical Co., Ltd, Taizhou, Zhejiang, CN |
| Date of update of the procedure | REGT | Jul 27, 2023 |